ARCHIVES

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

Study Reveals Racial Disparities In Surgical Prostate Care

August 31, 2012

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

July 28, 2000

In Brief: NCI Deputy Director Ihde To Leave Institute; Bynum To Retire; Lewis Thomas Dead At 80

December 10, 1993

Group Chairman Present A Counter-Proposal To NCI Committee

June 12, 1998

Study Finds No Evidence That Statins Cut Cancer Risk

January 27, 2006

In Brief: King Named To Replace Saunders; Zubrod Retires, Will Go To Miami; Perry acting Treatment Chief

June 14, 1974